title: Hypaque and steroids in the treatment of sudden sensorineural hearing loss.
abstract: While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.
authors.affiliation: Department of Otolaryngology, Chang Gung Medical College, Taipei, Taiwan, Republic of China.
authors.forename: T S
authors.initials: TS
authors.lastname: Huang
authors.forename: S T
authors.initials: ST
authors.lastname: Chan
authors.forename: T L
authors.initials: TL
authors.lastname: Ho
authors.forename: J L
authors.initials: JL
authors.lastname: Su
authors.forename: F P
authors.initials: FP
authors.lastname: Lee
mesh_terms: D000328:Adult; D001299:Audiometry; D001621:Betahistine / Q000627:therapeutic use*; D003974:Diatrizoate Meglumine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D011725:Pyridines; D003974:Diatrizoate Meglumine; D011239:Prednisolone; D001621:Betahistine